Amicus Therapeutics Financial Market Data
| Last Close 14-Aug-2008 |
$16.90 |
Price/ Sales Ratio |
45.06 |
| 52-Week High |
$18.22 |
Price/ Book Ratio |
4.40 |
| 52-Week Low |
$9.00 |
Price/ Earnings Ratio |
19.43 |
| 60-Month Beta |
-- |
Price/ Cash Flow Ratio |
18.46 |
| Market Cap (mil.) |
$380.5 |
Return on Assets |
0.0% |
| Shares Outstanding (mil.) |
22.5 |
Return on Equity |
0.0% |
| Dividend Rate |
-- |
Current Ratio |
9.58 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.02 |
| # of Institutional Holders |
53 |
% Owned by Institutions |
29.0% |
| Latest Short Interest Ratio |
70.40 |
Latest Net Insider Transactions |
545,999.00 |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
